Some Knossian Coins of Augustus

1975 ◽  
Vol 70 ◽  
pp. 7-9
Author(s):  
R. H. J. Ashton
Keyword(s):  
British Museum ◽  
Museum Specimen ◽  
The Third ◽  
Third Line ◽  
Image Position ◽  
Extended Discussion ◽  
Final Letter

The following rare issue of bronze coins has been ignored or misattributed by previous writers:Obverse: bare head of Augustus r.; behind head, AVGVS; border of dots.Reverse: within an olive wreath, or .The details of only five specimens, from one obverse die and two reverse dies, are available to me.The only extended discussion of this issue is in Grant, FITA 276–7, which was based solely on the Gotha coin and on a coin in the British Museum. The latter was not illustrated, but was most likely coin 2c, the Seager coin, which was an accession in 1926: 2b was an accession in 1948, two years after the publication of FITA, and nine years after the completion of its manuscript. Grant read the reverse legend of the Gotha coin as , noting that on the British Museum specimen the VE was not ligatured. But Grant's photograph of the Gotha coin, which is the only available record, yields under close examination no certain reading for the final letter of the third line: it could be D, O, or Q. There are, moreover, traces of only one letter on the fourth line, and again it is uncertain whether this is D, O, or Q (it looks in fact more like D than anything else).

scholarly journals Art. III.–On some Cuneiform Inscriptions of Sennacherib and Aššurnaṣirpal

1891 ◽  
Vol 23 (1) ◽  
pp. 145-160
Author(s):  
S. Arthur Strong
Keyword(s):  
British Museum ◽  
Single Group ◽  
The Third ◽  
Third Line

The following inscription, or rather group of three independent inscriptions, is on a tablet of clay numbered K 1280 in the Kouyunjik Collection of the British Museum. The tablet measures by 2⅜ in. (Bezold, Catalogue, p. 257). The obverse contains an inscription of nine lines complete in itself, the reverse two inscriptions of three and six lines respectively, which are separated by a line of division, and a single group of three characters appears on the edge. The texts are clearly written in characters which for the most part present the Assyrian form, though some, as, for instance, zu in the first and riš in the third line of the third inscription, are purely Babylonian.

What Worried the Crows?

1986 ◽  
Vol 36 (2) ◽  
pp. 534-537 ◽  
Author(s):  
Michael J. White
Keyword(s):  
Truth Conditions ◽  
Living Thing ◽  
Sextus Empiricus ◽  
The Third ◽  
Contemporary Perspective ◽  
The Common ◽  
Third Line ◽  
Image Position

A well-known epigram by Callimachus on the philosopher Diodorus Cronus (fr. 393 Pfeiffer) reads as follows:The question of the third line, while perhaps recondite from a contemporary perspective, was clear in antiquity. The crows are asking ‘What follows (from what)?’, in allusion to the Hellenistic disputes concerning the truth conditions of conditional propositions (συνημμ⋯να), disputes in which the views of Diodorus figured prominently.I agree with Sedley that the question of the last line is ‘much more problematic’. The common interpretation has been to read the αὖθι as a form of αὖθις and to interpret it temporally. The result, in Pfeiffer's estimation, is ‘quomodo posthac erimus?’.This interpretation derives from Sextus Empiricus' discussion at M. 1.309–12 of the last two lines of the epigram. After crediting the grammarian with the ability to understand the allusion in the crows' first question (M. 1.310: κα⋯ μ⋯χρι τούτου συνήσει τ⋯ κα⋯ παιδίοις γνώριμον), he proceeds to argue that the philosopher has a better chance than the grammarian of understanding the second question. But, to quote Sedley, Sextus ‘makes a ghastly mess of it’ when he attempts his own elucidation. According to an argument of Diodorus, a living thing does not die in the time in which it lives nor in a time in which it does not live. Hence, Sextus concludes, it must be the case that it never dies and, ‘if this is the case, we are always living and, according to him, we shall come to be hereafter (αὖθις γενησόμεθα)’ (M. 1.312).

scholarly journals AB0751 SAFETY AND PERSISTENCE OF USTEKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS IN BIOBADASER

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1672.2-1672
Author(s):  
N. Busquets-Pérez ◽  
C. Sánchez-Piedra ◽  
P. Vela-Casasempere ◽  
M. Freire-Gonzalez ◽  
C. Bohórquez ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Adverse Events ◽  
First Year ◽  
Line Treatment ◽  
Minimal Disease Activity ◽  
First Line ◽  
The Third ◽  
Minimal Disease ◽  
Second Year ◽  
Third Line

Background:Ustekinumab has been efficacy and safety for psoriatic artritis in clinical trials.Objectives:To assess effectiveness, by means of drug persistence analisys, and safety of ustekinumab in patients with psoriastic arthritis in Biobadaser.Methods:BIOBADASER is the Spanish registry of biological drugs of the Spanish Society of Rheumatology and the Spanish Medicines Agency. We identified patients aged 18 years or more with psoriatic arthritis on Ustekinumab. A descriptive analysis was performed.The persistence of ustekinumab therapy was calculated with a Kaplan-Meier curve and was compared with the persistence of anti-TNF, according to line treatment. Log Rank test was used to establish a comparison. Adverse events occurring with ustekinumab are described according to year treatment.Results:One hundred and twelve patients were on ustekinumab. Most of them were on their second or third line treatment: 53.57% more than one biological therapy (BT), 19.64% second BT, 26.79% were naïve for BT. Most of them were on 45 mg dose: 88.24%. Median duration of disease at Ustekinumab initiation was 10.1 SD 7.2 years; 69.23% had peripheral arthritis; 45.24% had obesity and 39.29% were overweight; 40,6% were on prednisone and 59.82% on DMARD. The cause of discontinuation of treatment was mainly inefficacy (82.61%) and less common an adverse event (6.52%). The probability of persistence of treatment with ustekinumab was 0.83 (95% CI 0.63-0.92) at year 1, 0.79 (0.58-0.90) at year 2 and 0.79 (0.58-0.9) at year 3 when ustekinumab was prescribed as the first line treatment. The persistence decrease when ustekinumab was prescribe as a second and third treatment: being 0.53 (0.27-0.73) the first year, 0.46 (0.22-0.67) the second year and 0.46 (0.22-0.67) as a second line treatment and 0.58 (0.44-0.70) the first year, 0.33 (0.17-0.50) the second year and 0.33 (0.17-0.50) the third year as a third line treatment.The persistence was similar to anti-TNF treatment, according to line treatment. Adverse events were mainly mild (97.83%) and occurred the first year of treatment. Most of the adverse events were classified as “infections and infestations” (36.96%).Conclusion:The persistence of ustekinumab was high, being 83% at the end of the first year on treatment and 79% the second and the third year of treatment. The persistence of ustekinumab was higher when if it was the first line treatment compared as if it was used as the second o third BT option. The persistence of Ustekinumab is similar to the persistence of anti-TNF treatments in all the analyzed treatment lines (no statistically differences were found). Adverse events occurred mainly during the first year treatment. They were mainly mild adverse events and the frequency decreased within the second and third year of treatment.References:[1]Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.Almirall M, Rodriguez J, Mateo L, Carrascosa JM, Notario J, Gallardo F. Clin Rheumatol. 2017 Feb;36(2):439-443;[2]Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.Napolitano M, Costa L, Caso F, Megna M, Scarpa R, Balato N, Ayala F, Balato A. J Clin Rheumatol. 2018 Oct;24(7):381-384;[3]Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.Queiro R, Brandy A, Rosado MC, Lorenzo A, Coto P, Carriles C, Alperi M, Ballina J. Actas Dermosifiliogr. 2018 Jun 28;[4]An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice.Salgüero Fernández I, Gil MH, Sanz MS, Gullón GR;Disclosure of Interests:None declared

scholarly journals Dislocation Arrangement in a Thick LEO GaN Film on Sapphire

2000 ◽  
Vol 5 (S1) ◽  
pp. 97-103
Author(s):  
Kathleen A. Dunn ◽  
Susan E. Babcock ◽  
Donald S. Stone ◽  
Richard J. Matyi ◽  
Ling Zhang ◽  
...  
Keyword(s):  
High Resolution ◽  
Electron Diffraction ◽  
Threading Dislocations ◽  
X Ray Diffraction ◽  
Burgers Vector ◽  
X Ray ◽  
The Third ◽  
Dislocation Arrangement ◽  
Image Position ◽  
Gan Film

Diffraction-contrast TEM, focused probe electron diffraction, and high-resolution X-ray diffraction were used to characterize the dislocation arrangements in a 16µm thick coalesced GaN film grown by MOVPE LEO. As is commonly observed, the threading dislocations that are duplicated from the template above the window bend toward (0001). At the coalescence plane they bend back to lie along [0001] and thread to the surface. In addition, three other sets of dislocations were observed. The first set consists of a wall of parallel dislocations lying in the coalescence plane and nearly parallel to the substrate, with Burgers vector (b) in the (0001) plane. The second set is comprised of rectangular loops with b = 1/3 [110] (perpendicular to the coalescence boundary) which originate in the coalescence boundary and extend laterally into the film on the (100). The third set of dislocations threads laterally through the film along the [100] bar axis with 1/3<110>-type Burgers vectors These sets result in a dislocation density of ∼109 cm−2. High resolution X-ray reciprocal space maps indicate wing tilt of ∼0.5º.

An Attic Dinos in the British Museum

1926 ◽  
Vol 46 (2) ◽  
pp. 250-252 ◽  
Author(s):  
J. H. Iliffe
Keyword(s):  
British Museum ◽  
The Third

B.M. B46. The catalogue describes this vase thus:—Acquired 1867: Blacas Coll. Dinos. Ht. 13 in. Diam. 12½ in. Slightly restored, imperfectly fired. Around rim, chain of lotus and buds; on shoulder, tongue-pattern. Two friezes: above, banquet scene, of seven couches, on each of which two male banqueters; between the two end couches, group of five servants, in attendance on the banqueters; below, animal frieze. Beneath this a broad zone of black, and on bottom, polypus pattern.The principal scene shows a series of seven couches, on each of which recline two bearded male figures, facing to 1.; seven of them wear wreaths. Alongside each couch stands a table, bearing viands for the banquet. From 1. to r., the first, fourth, sixth, tenth and thirteenth hold out phialae in varying attitudes; the third, eleventh and fourteenth hold out kerata, in the act of drinking, or to have them refilled, while the seventh and eighth also have each a keras; the fifth holds out a kantharos; the twelfth raises an apparently empty r. hand; the second also raises his r. hand, but the object he holds is hidden by the first figure; the ninth plays the double flute.

Testing for Language Teachers

2020 ◽  
Author(s):  
Arthur Hughes ◽  
Jake Hughes
Keyword(s):  
Adaptive Testing ◽  
Language Teachers ◽  
Experienced Teachers ◽  
Automated Scoring ◽  
Testing Methods ◽  
The Third ◽  
Recent Developments ◽  
Extended Discussion ◽  
Straightforward Approach ◽  
Practical Recommendations

This book provides an accessible guide to concepts in language testing and the testing of specific skills and systems. It combines theory and practical recommendations to help teachers understand the principles of testing and how they can be applied, supporting them to write better tests. The third edition has been extensively revised and updated to reflect recent developments in the field, while retaining the straightforward approach that made the earlier editions essential reading for trainee and experienced teachers alike. It features new content on technology, including computer adaptive testing and the use of automated scoring for all skills. It also includes an extended discussion of language testers' responsibilities, new chapters on non-testing methods of assessment and a checklist to help teachers choose tests.

scholarly journals The combination of TAS-102 and bevacizumab as the third line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study)

2018 ◽  
Vol 29 ◽  
pp. viii157
Author(s):  
H. Kamiyama ◽  
Y. Yoshida ◽  
H. Yoshida ◽  
C. Kosugi ◽  
K. Ishibashi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
The Third ◽  
Third Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document